Evidence map›Paper›PMID 35001400›Full record

SynthesisAllergy2022

Allergen immunotherapy and/or biologicals for IgE-mediated food allergy: A systematic review and meta-analysis.

Debra de Silva, Pablo Rodríguez Del Río, Nicolette W de Jong, Ekaterina Khaleva, Chris Singh, Anna Nowak-Wegrzyn, Antonella Muraro, Philippe Begin, Giovanni Pajno, Alessandro Fiocchi and 14 more

Registry-linked trialOpen access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Allergy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06328504 (Efficacy of Cashew Nut Protein Immunotherapy), which is not on this map. Cited by 61 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 5 pooled it
18.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06328504 narecruitingnot on this mapstarted 2024, after this paper: background citation

Efficacy of Cashew Nut Protein Immunotherapy

TypeinterventionalSponsorMedical University of WarsawRan2024 to 2027Enrolled39ConditionsFood AllergyArmsCashew immunotherapy
3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 5 syntheses or guidelines pooled it, 134 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Pragmatic Low-Dose Oral Immunotherapy for Preschool Children With Peanut Allergy: A Randomised Controlled Trial.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2025
    Trial
  8. Review
  9. CaClinical and experimental pharmacology & physiology · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Children Allergic to Peanut and/or Tree Nuts Are at Risk of Accidental Allergic Reactions.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026
    Article
  18. Immunotherapy in Peanut Allergy: The Present and the Future.Allergy, asthma & immunology research · 2025
    Article
  19. Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 20 institutions in 12 countries.

Debra de SilvaThe Evidence Centre, London, UK.ORCID 0000-0001-8413-5487
Pablo Rodríguez Del RíoNiño Jesus University Children's Hospital, Madrid, Spain.ORCID 0000-0002-0783-1988
Nicolette W de JongUniversity Medical Centre Rotterdam, Rotterdam, The Netherlands.
Ekaterina KhalevaUniversity of Southampton, London, UK.ORCID 0000-0002-2220-7745
Chris SinghThe Evidence Centre, Wellington, New Zealand.
Anna Nowak-WegrzynNYU Langone Health, New York, New York, USA.ORCID 0000-0002-0960-9854
Antonella MuraroPadua University Hospital, Padua, Italy.ORCID 0000-0002-5026-5862
Philippe BeginUniverisite de Montreal, Montreal, QC, Canada.ORCID 0000-0002-9089-4604
Giovanni PajnoPoliclinico Hospital-University of Messina, Messina, Italy.
Alessandro FiocchiBambino Gesù Childrens' Hospital IRCCS, Rome, Italy.ORCID 0000-0002-2549-0523
Angel SanchezAEPNAA Spanish Association for People with Food and Latex Allergy, Madrid, Spain.
Carla JonesAllergy UK, London, UK.
Caroline NilssonKarolinska Institutet and Sachs´ Children and Youth Hospital, Stockholm, Sweden.ORCID 0000-0003-2040-8428
Carsten Bindslev-JensenOdense University Hospital, Odense, Denmark.ORCID 0000-0002-8940-038X
Gary WongChinese University of Hong Kong, Hong Kong, Hong Kong.ORCID 0000-0001-5939-812X
Hugh SampsonMount Sinai School of Medicine, New York, New York, USA.ORCID 0000-0003-1613-8875
Kirsten BeyerCharité-Universitätsmedizin Berlin, Berlin, Germany.
Mary-Jane MarchisottoEAACI Patient Organisation Committee Chair, New York, New York, USA.
Montserrat Fernandez RivasHospital Clínico San Carlos, Madrid, Spain.ORCID 0000-0003-1748-2328
Rosan MeyerImperial College, London, UK.ORCID 0000-0002-5710-5570
Susanne LauCharité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0002-5189-4265
Ulugbek NurmatovCardiff University, Cardiff, UK.ORCID 0000-0002-9557-8635
Graham RobertsUniversity of Southampton, London, UK.ORCID 0000-0003-2252-1248
GA2LEN Food Allergy Guidelines Group
Charité - Universitätsmedizin Berlin · DEUniversity of Southampton · GBAsociación Española Contra el Cáncer · ESBambino Gesù Children's Hospital · ITCardiff University · GBChinese University of Hong Kong · HKENT and Allergy · USEuropean CanCer Organisation · BEHospital Clínico San Carlos · ESHospital Infantil Universitario Niño Jesús · ESIcahn School of Medicine at Mount Sinai · USImperial College London · GBKarolinska Institutet · SENYU Langone Health · USOdense University Hospital · DKRotterdam University of Applied Sciences · NLThe Family Centre · NZUniversité de Montréal · CAUniversity of Messina · ITUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is substantial interest in immunotherapy and biologicals in IgE-mediated food allergy.

methodsWe searched six databases for randomized controlled trials about immunotherapy alone or with biologicals (to April 2021) or biological monotherapy (to September 2021) in food allergy confirmed by oral food challenge. We pooled the data using random-effects meta-analysis.

resultsWe included 36 trials about immunotherapy with 2126 mainly child participants. Oral immunotherapy increased tolerance whilst on therapy for peanut (RR 9.9, 95% CI 4.5.-21.4, high certainty); cow's milk (RR 5.7, 1.9-16.7, moderate certainty) and hen's egg allergy (RR 8.9, 4.4-18, moderate certainty). The number needed to treat to increase tolerance to a single dose of 300 mg or 1000 mg peanut protein was 2. Oral immunotherapy did not increase adverse reactions (RR 1.1, 1.0-1.2, low certainty) or severe reactions in peanut allergy (RR 1,6, 0.7-3.5, low certainty), but may increase (mild) adverse reactions in cow's milk (RR 3.9, 2.1-7.5, low certainty) and hen's egg allergy (RR 7.0, 2.4-19.8, moderate certainty). Epicutaneous immunotherapy increased tolerance whilst on therapy for peanut (RR 2.6, 1.8-3.8, moderate certainty). Results were unclear for other allergies and administration routes. There were too few trials of biologicals alone (3) or with immunotherapy (1) to draw conclusions.

conclusionsOral immunotherapy improves tolerance whilst on therapy and is probably safe in peanut, cow's milk and hen's egg allergy. More research is needed about quality of life, cost and biologicals.

Indexed as

Egg HypersensitivityFood HypersensitivityAllergensAnimalsCattleChickensDesensitization, ImmunologicFemaleHumansImmunoglobulin EQuality of LifeAllergensImmunoglobulin Ebiologicalfood allergyIgE-mediatedimmunotherapypeanut

Identifiers

PMID35001400
PMCPMC9303769
OpenAlexW4205577581

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.